Insulin-Like Growth Factor Binding Protein 7 (IGFBP7) Peptide
Aperçu rapide pour Insulin-Like Growth Factor Binding Protein 7 (IGFBP7) Peptide (ABIN8103137)
Antigène
Source
Application
-
-
Fonction
- IGFBP7 Peptide
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Commentaires
-
This is a synthetic peptide designed for use in combination with anti-IGFBP7 antibody ( ARP48174_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- IGFBP7 (Insulin-Like Growth Factor Binding Protein 7 (IGFBP7))
-
Sujet
-
Background Information: IGFBP7 contains 1 Ig-like C2-type (immunoglobulin-like) domain, 1 IGFBP N-terminal domain and 1 Kazal-like domain. It binds IGF-I and IGF-II with a relatively low affinity. IGFBP7 stimulates prostacyclin (PGI2) production.
Alternative Symbols: FSTL2, IGFBP-7, IGFBP-7v, MAC25, PSF, AGM, TAF, IBP-7, RAMSVPS, IGFBPRP1
-
Poids moléculaire
- 29kDa
-
ID gène
- 3490
-
NCBI Accession
- NP_001544
-
UniProt
- Q16270
Antigène
-